Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Eugene A. Kiyatkin. (2019) Brain temperature and its role in physiology and pathophysiology: Lessons from 20 years of thermorecording. Temperature 6:4, pages 271-333.
Read now
Read now
Anya K. Bershad, Jessica J. Weafer, Matthew G. Kirkpatrick, Margaret C. Wardle, Melissa A. Miller & Harriet de Wit. (2016) Oxytocin receptor gene variation predicts subjective responses to MDMA. Social Neuroscience 11:6, pages 592-599.
Read now
Read now
Timothy Amoroso. (2015) The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder. Journal of Psychoactive Drugs 47:5, pages 337-344.
Read now
Read now
Adam Michael Stewart & Allan V Kalueff. (2014) Anxiolytic drug discovery: what are the novel approaches and how can we improve them?. Expert Opinion on Drug Discovery 9:1, pages 15-26.
Read now
Read now
Amy Emerson, Linnae Ponté, Lisa Jerome & Rick Doblin. (2014) History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS). Journal of Psychoactive Drugs 46:1, pages 27-36.
Read now
Read now
Andrew C. Parrott. (2014) The Potential Dangers of Using MDMA for Psychotherapy. Journal of Psychoactive Drugs 46:1, pages 37-43.
Read now
Read now
Lwendo
S. Moonzwe, Jean
J. Schensul & Kristin
M. Kostick. (2011) The Role of MDMA (Ecstasy) in Coping with Negative Life Situations Among Urban Young Adults. Journal of Psychoactive Drugs 43:3, pages 199-210.
Read now
Read now
R. L. Carhart-Harris & D. J. Nutt. (2010) User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use 15:4, pages 283-300.
Read now
Read now
José
Carlos Bouso, Rick Doblin, Magí Farré, Miguel
Ángel Alcázar & Gregorio Gómez-Jarabo. (2008) MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder. Journal of Psychoactive Drugs 40:3, pages 225-236.
Read now
Read now
Jeff Sigafoos, Vanessa A. Green, Chaturi Edrisinha & Giulio E. Lancioni. (2007) Flashback to the 1960s: LSD in the treatment of autism. Developmental Neurorehabilitation 10:1, pages 75-81.
Read now
Read now
Robert Klitzman. (2006) From “Male Bonding Rituals” to “Suicide Tuesday”. Journal of Homosexuality 51:3, pages 7-32.
Read now
Read now
Arthur Hastings. (2006) An Extended Nondrug MDMA-Like Experience Evoked Through Posthypnotic Suggestion. Journal of Psychoactive Drugs 38:3, pages 273-283.
Read now
Read now
Harris Friedman. (2006) The Renewal of Psychedelic Research: Implications for Humanistic and Transpersonal Psychology. The Humanistic Psychologist 34:1, pages 39-58.
Read now
Read now
Articles from other publishers (54)
Geoffrey B. Varty, Clinton E. Canal, Tina A. Mueller, Joshua A. Hartsel, Richa Tyagi, Ken Avery, Michael E. Morgan, Amy C. Reichelt, Pradip Pathare, Erik Stang, Michael G. Palfreyman & Alex Nivorozhkin. (2024)
Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT
2
Receptor Agonist
. Journal of Medicinal Chemistry 67:8, pages 6144-6188.
Crossref
Crossref
Jennifer M. Mitchell, Marcela Ot’alora G., Bessel van der Kolk, Scott Shannon, Michael Bogenschutz, Yevgeniy Gelfand, Casey Paleos, Christopher R. Nicholas, Sylvestre Quevedo, Brooke Balliett, Scott Hamilton, Michael Mithoefer, Sarah Kleiman, Kelly Parker-Guilbert, Keren Tzarfaty, Charlotte Harrison, Alberdina de Boer, Rick Doblin & Berra Yazar-Klosinski. (2023) MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine 29:10, pages 2473-2480.
Crossref
Crossref
Inês Hipólito, Jonas Mago, Fernando E Rosas & Robin Carhart-Harris. (2023) Pattern breaking: a complex systems approach to psychedelic medicine. Neuroscience of Consciousness 2023:1.
Crossref
Crossref
Allison Feduccia, Gabby Agin-Liebes, Collin M. Price, Nicole Grinsell, Summer Paradise & David M. Rabin. (2023) The need for establishing best practices and gold standards in psychedelic medicine. Journal of Affective Disorders 332, pages 47-54.
Crossref
Crossref
Pedro Mota, Joana Proença Becker & Manuel João Quartilho. (2022) Psicoterapia Assistida por MDMA: um Novo Paradigma no Tratamento da Perturbação de Stress Pós‐Traumático Resistente?. Revista Portuguesa de Psiquiatria e Saúde Mental 8:4, pages 141-147.
Crossref
Crossref
V. L. Matrenitsky. (2022) РЕНЕСАНС ПСИХОДЕЛІЧНОЇ ТЕРАПІЇ ТА ЇЇ ЗНАЧЕННЯ ДЛЯ УКРАЇНИ. Likarska sprava:3-4, pages 37-59.
Crossref
Crossref
Mitchell D. Arnovitz, Andrew J. Spitzberg, Ashkhan J. Davani, Nehal P. Vadhan, Julie Holland, John M. Kane & Timothy I. Michaels. (2022) MDMA for the Treatment of Negative Symptoms in Schizophrenia. Journal of Clinical Medicine 11:12, pages 3255.
Crossref
Crossref
Ben Sessa, Jacob S Aday, Steve O’Brien, H Valerie Curran, Fiona Measham, Laurie Higbed & David J Nutt. (2021) Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA. Journal of Psychopharmacology 36:3, pages 360-367.
Crossref
Crossref
Benjamin JG Illingworth, Declan J Lewis, Andrew T Lambarth, Kate Stocking, James MN Duffy, Luke A Jelen & James J Rucker. (2020) A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. Journal of Psychopharmacology 35:5, pages 501-511.
Crossref
Crossref
Katherine Hendy. (2020) MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials. Medical Anthropology Quarterly 35:1, pages 5-24.
Crossref
Crossref
Benjamin Stewart, Jon G. Dean, Adriana Koek, Jason Chua, Rafael Wabl, Kayla Martin, Naveed Davoodian, Christopher Becker, Mai Himedan, Amanda Kim, Roger Albin, Kelvin L. Chou & Vikas Kotagal. (2020) Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports. Pharmacology Research & Perspectives 8:6.
Crossref
Crossref
Anees Bahji, Ashleigh Forsyth, Dianne Groll & Emily R. Hawken. (2020) Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 96, pages 109735.
Crossref
Crossref
Marija Petrin Miličević, Sanja Belić, Milan Vraneš, Aleksandar Tot, Nataša Radosavljević Stevanović, Dušica Rakić & Slobodan Gadžurić. (2020) Volumetric properties, viscosity and taste behavior of MDMA-HCl in aqueous binary and (water + D-lactose) ternary mixtures at different temperatures. The Journal of Chemical Thermodynamics 142, pages 106027.
Crossref
Crossref
Kevin Sean Murnane. (2019) Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder. Behavioural Pharmacology 30:2 and 3, pages 151-162.
Crossref
Crossref
Patricio Sáez-Briones, Vicente Castro-Castillo, Gabriela Díaz-Véliz, Luis Valladares, Rafael Barra, Alejandro Hernández & Bruce K. Cassels. (2019) Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT). Frontiers in Pharmacology 10.
Crossref
Crossref
Sascha B. Thal & Miriam J. J. Lommen. (2018) Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Contemporary Psychotherapy 48:2, pages 99-108.
Crossref
Crossref
Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire, Matthew B. Young & Leonard L. Howell. (2017) (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA. Psychopharmacology 235:2, pages 377-392.
Crossref
Crossref
Kevin S. Murnane. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience
25
67
.
Shawn M. Aarde, Pai-Kai Huang & Michael A. Taffe. (2017) High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration. Pharmacology Biochemistry and Behavior 163, pages 38-49.
Crossref
Crossref
Jakob A. Shimshoni, Ilan Winkler, Ezekiel Golan & David Nutt. (2016) Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn-Schmiedeberg's Archives of Pharmacology 390:1, pages 15-24.
Crossref
Crossref
Alicia L. Danforth, Christopher M. Struble, Berra Yazar-Klosinski & Charles S. Grob. (2016) MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 237-249.
Crossref
Crossref
Daniel Toledano & Pascale Gisquet-Verrier. (2014) Only susceptible rats exposed to a model of PTSD exhibit reactivity to trauma-related cues and other symptoms: An effect abolished by a single amphetamine injection. Behavioural Brain Research 272, pages 165-174.
Crossref
Crossref
Andrew C. Parrott. (2014)
MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin
et al
. (2014)
. Human Psychopharmacology: Clinical and Experimental 29:2, pages 109-119.
Crossref
Crossref
Nikhil Neelkantan, Alina Mikhaylova, Adam Michael Stewart, Raymond Arnold, Visar Gjeloshi, Divya Kondaveeti, Manoj K. Poudel & Allan V. Kalueff. (2013) Perspectives on Zebrafish Models of Hallucinogenic Drugs and Related Psychotropic Compounds. ACS Chemical Neuroscience 4:8, pages 1137-1150.
Crossref
Crossref
Andrew C. Parrott. (2013) Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. Human Psychopharmacology: Clinical and Experimental 28:4, pages 289-307.
Crossref
Crossref
Frank J. Farach, Larry D. Pruitt, Janie J. Jun, Alissa B. Jerud, Lori A. Zoellner & Peter P. Roy-Byrne. (2012) Pharmacological treatment of anxiety disorders: Current treatments and future directions. Journal of Anxiety Disorders 26:8, pages 833-843.
Crossref
Crossref
M.-H. Ghysel-Laporte, P. Sibille & N. Milan. 2012. Traité De Toxicologie Médico-judiciaire. Traité De Toxicologie Médico-judiciaire
455
505
.
Vivian Capilla-Gonzalez & Vicente Hernandez-Rabaza. (2011) Cocaine and MDMA Induce Cellular and Molecular Changes in Adult Neurogenic Systems: Functional Implications. Pharmaceuticals 4:6, pages 915-932.
Crossref
Crossref
Judith Cukor, Josh Spitalnick, JoAnn Difede, Albert Rizzo & Barbara O. Rothbaum. (2009) Emerging treatments for PTSD. Clinical Psychology Review 29:8, pages 715-726.
Crossref
Crossref
Laura A. León, Jesus Landeira-Fernandez & Fernando P. Cardenas. (2009) Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress. Behavioural Brain Research 205:1, pages 259-264.
Crossref
Crossref
Sanjeev Bhattacharyya, Anthony H Schapira, Dimitri P Mikhailidis & Joseph Davar. (2009) Drug-induced fibrotic valvular heart disease. The Lancet 374:9689, pages 577-585.
Crossref
Crossref
João Paulo Capela, Helena Carmo, Fernando Remião, Maria Lourdes Bastos, Andreas Meisel & Félix Carvalho. (2009) Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview. Molecular Neurobiology 39:3, pages 210-271.
Crossref
Crossref
J. C. Winter. (2008) Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology 203:2, pages 251-263.
Crossref
Crossref
Michael H. Baumann & Richard B. Rothman. 2009. New Concepts of Psychostimulant Induced Neurotoxicity. New Concepts of Psychostimulant Induced Neurotoxicity
257
296
.
Harold Hall, Sandra McPherson & Errol YudkoSandra Mcpherson & Errol Yudko. 2008. Methamphetamine Use. Methamphetamine Use
51
63
.
Steven Berman, Joseph O'Neill, Scott Fears, George Bartzokis & Edythe D. London. (2008) Abuse of Amphetamines and Structural Abnormalities in the Brain. Annals of the New York Academy of Sciences 1141:1, pages 195-220.
Crossref
Crossref
M. A. Starr, M. E. Page & B. D. Waterhouse. (2008) MDMA (3,4-Methylenedioxymethamphetamine)-Mediated Distortion of Somatosensory Signal Transmission and Neurotransmitter Efflux in the Ventral Posterior Medial Thalamus. Journal of Pharmacology and Experimental Therapeutics 327:1, pages 20-31.
Crossref
Crossref
Gerald Zapata-Torres, Bruce K. Cassels, Julia Parra-Mouchet, Yvonne P. Mascarenhas, Javier Ellena & A.S. De Araujo. (2008) Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane. Journal of Molecular Graphics and Modelling 26:8, pages 1296-1305.
Crossref
Crossref
John R. Beuerle & Fermin Barrueto. (2008) Neurogenic bladder and chronic urinary retention associated with MDMA abuse. Journal of Medical Toxicology 4:2, pages 106-108.
Crossref
Crossref
Boris Mlinar, Simona Mascalchi, Raffaella Morini, Filippo Giachi & Renato Corradetti. (2007) MDMA Induces EPSP–Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT4 and β1 Receptors. Neuropsychopharmacology 33:6, pages 1464-1475.
Crossref
Crossref
Michael Baumann & Richard Rothman. 2007. Neurochemistry of Abused Drugs. Neurochemistry of Abused Drugs
119
142
.
Kyung-Ok Cho, Seul-Ki Kim, Gyu Seek Rhee, Seung Jun Kwack, Dae Hyun Cho, Ki-Wug Sung & Seong Yun Kim. (2007) Chronic 3,4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus. European Journal of Pharmacology 566:1-3, pages 120-123.
Crossref
Crossref
Brian J. Piper. (2007) A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicology and Teratology 29:2, pages 288-300.
Crossref
Crossref
A. C. Parrott. (2007) The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Psychopharmacology 191:2, pages 181-193.
Crossref
Crossref
Michael H. Baumann, Xiaoying Wang & Richard B. Rothman. (2006) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189:4, pages 407-424.
Crossref
Crossref
Julie Staley & Kelly Cosgrove. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
429
558
.
Ronald L. Cowan. (2006) Neuroimaging research in human MDMA users: a review. Psychopharmacology 189:4, pages 539-556.
Crossref
Crossref
Andy C. Parrott. (2016) MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Journal of Psychopharmacology 20:2, pages 147-163.
Crossref
Crossref
Neil Easton & Charles A. Marsden. (2016) Ecstasy: Are animal data consistent between species and can they translate to humans?. Journal of Psychopharmacology 20:2, pages 194-210.
Crossref
Crossref
Claire E. Sterk, Katherine P. Theall & Kirk W. Elifson. (2016) Young Adult Ecstasy use Patterns: Quantities and Combinations. Journal of Drug Issues 36:1, pages 201-228.
Crossref
Crossref
Maartje M.L. De Win, Gerry Jager, Hylke K.E. Vervaeke, Thelma Schilt, Liesbeth Reneman, Jan Booij, Frank C. Verhulst, Gerard J. Den Heeten, Nick F. Ramsey, Dirk J. Korf & Wim Van Den Brink. (2005) The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research 14:4, pages 167-185.
Crossref
Crossref
P. Leon Brown & Eugene A. Kiyatkin. (2004) Brain hyperthermia induced by MDMA (‘ecstasy’): modulation by environmental conditions. European Journal of Neuroscience 20:1, pages 51-58.
Crossref
Crossref
John H. Halpern. (2003) Hallucinogens: An update. Current Psychiatry Reports 5:5, pages 347-354.
Crossref
Crossref
José Carlos Bouso Saiz & Gregorio Gómez-Jarabo. (2003) Investigación terapéutica con MDMA («éxtasis»). Medicina Clínica 121:8, pages 318.
Crossref
Crossref